Journal article

Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial

M Grossmann, KP Robledo, M Daniel, DJ Handelsman, WJ Inder, BGA Stuckey, BB Yeap, M Ng Tang Fui, K Bracken, CA Allan, D Jesudason, JD Zajac, GA Wittert

Journal of Clinical Endocrinology and Metabolism (JCEM) | Oxford University Press | Published : 2024

Abstract

Objective: To determine the effect of testosterone vs placebo treatment on health-related quality of life (HR-QOL) and psychosocial function in men without pathologic hypogonadism in the context of a lifestyle intervention. Design, Setting, Participants: Secondary analysis of a 2-year randomized controlled testosterone therapy trial for prevention or reversal of newly diagnosed type 2 diabetes, enrolling men ≥ 50 years at high risk for type 2 diabetes from 6 Australian centers. Interventions: Injectable testosterone undecanoate or matching placebo on the background of a community-based lifestyle program. Main Outcomes: Self-reported measures of HR-QOL/psychosocial function. Results: ..

View full abstract